Mark de Souza
Mark De Souza is the chief executive officer of Penrose TherapeuTx, a pharmaceutical company based in Plymouth, Michigan. He also served as CEO of Revolution Global, a cannabis producer. from October 2016 to October 2020. He was previously president and executive director of global business development of County Cork, LLC, a CTA.
De Souza joined County Cork in June of 2012. He has been in the field since 1985, when he joined as a member of the Chicago Board of Trade, specializing in institutional order execution in the interest rate quadrant. He became a member of the Chicago Mercantile Exchange in 1992 and joined as a partner in International Futures and Options Associates. He also served on several CME internal governing committees, including the Broker Association Committee, the Business Conduct (Financial Division) Committee, and the Eurodollar Configuration Advisory Committee. In addition, de Souza was a member of the CME Political Action Committee and participated in the Congressional lobbying efforts on legislative and regulatory issues affecting the Futures industry.
He worked in the U.A.E in 2005 to establish capital relationships for various U.S. based fund managers. 
De Souza also served as a Principal (Series 3, 7, 24, 62, 63, 65 licenses) of Spike Financial Services, a NASD broker dealer and as a founding partner and COO of Titan Holdings, LLC.
De Souza was educated at the University of Illinois at Chicago.
JLN News Feed
Why everyone is now an options trader; Strategists See Growing Bets on Emerging-Markets Via ETF Options
Nasdaq Announces End-of-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date May 28, 2021
[JPX,TSE,OSE,JPX-R,JSCC,TOCOMJPX Monthly Headlines - May 2021]
CME Group Chairman and Chief Executive Officer Terry Duffy to Present at Piper Sandler Global Exchange and FinTech Virtual Conference
We visit more than 100 websites daily for financial news (Would YOU do that?). Read the John Lothian Newsletter.